Ad is loading...
FTVSX
Price
$36.25
Change
+$0.44 (+1.23%)
Updated
Nov 22 closing price
JVMIX
Price
$32.25
Change
+$0.32 (+1.00%)
Updated
Nov 22 closing price
Ad is loading...

FTVSX vs JVMIX

Header iconFTVSX vs JVMIX Comparison
Open Charts FTVSX vs JVMIXBanner chart's image
FullerThaler Behav Md-Cp Val Instl
Price$36.25
Change+$0.44 (+1.23%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap I
Price$32.25
Change+$0.32 (+1.00%)
VolumeN/A
CapitalizationN/A
FTVSX vs JVMIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTVSX vs. JVMIX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTVSX is a Buy and JVMIX is a Buy.

FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 24.2B vs. FTVSX (397M). FTVSX pays higher dividends than JVMIX: FTVSX (1.56) vs JVMIX (0.84). FTVSX was incepted earlier than JVMIX: FTVSX (7 years) vs JVMIX (27 years). JVMIX is a more actively managed with annual turnover of: 41.00 vs. FTVSX (15.00). FTVSX has a lower initial minimum investment than JVMIX: FTVSX (100000) vs JVMIX (250000). FTVSX annual gain was more profitable for investors over the last year : 28.47 vs. JVMIX (22.12). FTVSX return over 5 years is better than : 67.82 vs. JVMIX (48.14).
FTVSXJVMIXFTVSX / JVMIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years27 years-
Gain YTD14.51916.66187%
Front LoadN/AN/A-
Min. Initial Investment10000025000040%
Min. Initial Investment IRAN/AN/A-
Net Assets397M24.2B2%
Annual Yield % from dividends1.560.84185%
Returns for 1 year28.4722.12129%
Returns for 3 years17.9911.06163%
Returns for 5 years67.8248.14141%
Returns for 10 yearsN/A63.69-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRI6.410.32
+5.25%
Stoneridge
UK1.220.04
+3.39%
Ucommune International Ltd
BOWL11.830.26
+2.25%
Bowlero Corp
RHI73.701.09
+1.50%
Robert Half
RGLS1.40N/A
N/A
Regulus Therapeutics